FINE-START: Efficacy and Safety of Finerenone in Patients With Chronic Kidney Disease Not Using Renin-angiotensin-system Inhibitors
A phase 3 trial registered on ClinicalTrials.gov. The registry status is enrolling by invitation. It plans to enroll 180 participants.
Also called NCT07181135
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 180 participants
- Registry
-
NCT07181135 -
2025-523075-32-00
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Spain
- Registry status
- Enrolling by invitation
Technical summary
Registry record NCT07181135. Randomized; double masking; primary purpose treatment. Start 2026-03-13 (actual); primary completion 2027-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- FINE-START: Efficacy and Safety of Finerenone in Patients With Chronic Kidney Disease Not Using Renin-angiotensin-system Inhibitors
- Acronym
- FINE-START
- Condition
- Chronic Kidney Disease
- Intervention (Drug)
- Finerenone (BAY 94-8862)
- Intervention (Drug)
- Placebo
- Lead sponsor
- University Medical Center Groningen
Record details
- Record id
cardio:ct-nct07181135- Content hash
17eeaeacbb9af12bd6394d50129a3a3aea15d162b5b99e54e9afc1fee7348540